JoVE Logo

로그인

7.5 : Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.

Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more drugs and are blocked faster than muscles with a lesser blood supply and a smaller blood flow. The drug's actions are terminated when redistributed to other tissues. The duration of action is directly correlated to the elimination half-life. Some drugs like pancuronium, d-tubocurarine, doxacurium and pipecuronium are excreted unchanged in the urine and have a long elimination half-life and duration of action lasting more than 60 minutes. Other drugs like atracurium and cisatracurium undergo spontaneous ester hydrolysis in plasma. Certain amino steroid blockers like vecuronium and rocuronium are metabolized in the liver. Although such metabolites have half the activity of the parent drug, they are usually not formed in amounts required to produce blockade. The drugs metabolized in the plasma or liver have a shorter elimination half-life and action duration lasting only 20 to 40 minutes. Other drugs are also excreted unchanged through the bile.

Tags

Nondepolarizing Neuromuscular BlockersPharmacokineticsIntravenous AdministrationMuscle Blood SupplyDrug RedistributionElimination Half lifePancuroniumD tubocurarineDoxacuriumPipecuroniumAtracuriumCisatracuriumVecuroniumRocuroniumSpontaneous Ester Hydrolysis

장에서 7:

article

Now Playing

7.5 : Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

Skeletal Muscle Relaxants

429 Views

article

7.1 : 신경근 접합부 및 봉쇄

Skeletal Muscle Relaxants

2.8K Views

article

7.2 : 골격근 이완제의 분류

Skeletal Muscle Relaxants

2.4K Views

article

7.3 : Nondepolarizing (Competitive) 신경근 차단제: 작용 기전

Skeletal Muscle Relaxants

1.4K Views

article

7.4 : Nondepolarizing (Competitive) Neuromuscular Blockers: 약리학적 작용

Skeletal Muscle Relaxants

386 Views

article

7.6 : 탈분극 차단제: 작용 메커니즘

Skeletal Muscle Relaxants

1.2K Views

article

7.7 : 탈분극 차단제: Pharmocokinetics

Skeletal Muscle Relaxants

305 Views

article

7.8 : 직접 작용하는 근육 이완제: 단트롤렌과 보툴리눔 독소

Skeletal Muscle Relaxants

653 Views

article

7.9 : 골격근 이완제: 부작용

Skeletal Muscle Relaxants

332 Views

article

7.10 : 골격근 이완제: 치료 용도

Skeletal Muscle Relaxants

462 Views

article

7.11 : 경련 용해제: 화학적 분류

Skeletal Muscle Relaxants

853 Views

article

7.12 : Peripherally and Central Acting Muscle Relaxants: A Comparison (말초와 중추 작용 근육 이완제: 비교)

Skeletal Muscle Relaxants

3.1K Views

article

7.13 : 중추 작용 근육 이완제 : 치료 용도

Skeletal Muscle Relaxants

617 Views

JoVE Logo

개인 정보 보호

이용 약관

정책

연구

교육

JoVE 소개

Copyright © 2025 MyJoVE Corporation. 판권 소유